| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0.82 | 1.11 | 5.61 | 0.49 | 0.5 |
| Stock Adjustments | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0.82 | 1.11 | 5.61 | 0.49 | 0.5 |
| EXPENDITURE : | |||||
| Raw Materials | 0 | 0 | 0 | 0 | 0 |
| Excise Duty | 0 | 0 | 0 | 0 | 0 |
| Power and Fuel Cost | 0.03 | 0 | 0 | 0 | 0 |
| Other Manufacturing Expenses | 0.02 | 0 | 0 | 0 | 0 |
| Employee Cost | 0.21 | 0.13 | 0.06 | 0.03 | 0.01 |
| Selling and Administration Expenses | 0.3 | 0.21 | 0.16 | 0.14 | 0.11 |
| Miscellaneous Expenses | 0 | 0 | 0.05 | 0 | 0 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | 0.26 | 0.77 | 5.34 | 0.32 | 0.38 |
| Interest and Financial Charges | 0 | 0 | 0 | 0 | 0 |
| Profit before Depreciation and Tax | 0.26 | 0.77 | 5.34 | 0.32 | 0.38 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0.26 | 0.76 | 5.33 | 0.32 | 0.38 |
| Tax | 0.05 | 0.66 | 0.65 | 0.1 | 0.1 |
| Profit After Tax | 0.21 | 0.1 | 4.68 | 0.22 | 0.28 |
| Adjustment below Net Profit | 0 | 0 | 0 | 0 | -0.01 |
| P and L Balance brought forward | 3.48 | 3.38 | -1.3 | -1.52 | -1.79 |
| Appropriations | 0 | 0 | 0 | 0 | 0 |
| P and L Bal. carried down | 3.69 | 3.48 | 3.38 | -1.3 | -1.52 |
| Equity Dividend | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 1.38 | 0.67 | 31.23 | 1.45 | 1.87 |
| Book Value | 68.86 | 67.49 | 66.82 | 35.59 | 34.14 |
| Extraordinary Items | 0 | 0 | 4.45 | 0 | 0 |
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 |
| Reserves and Surplus | 8.83 | 8.62 | 8.52 | 3.84 | 3.62 |
| Total Shareholders Funds | 10.33 | 10.12 | 10.02 | 5.34 | 5.12 |
| Secured Loans | 0 | 0 | 0.12 | 0 | 0 |
| Unsecured Loans | 0 | 0 | 0 | 0.12 | 0.12 |
| Total Debt | 0 | 0 | 0.12 | 0.12 | 0.12 |
| Total Liabilities | 10.33 | 10.12 | 10.14 | 5.46 | 5.24 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 0.01 | 0.01 | 0.09 | 0.09 | 0.09 |
| Less: Accum. Depreciation | 0.01 | 0 | 0.08 | 0.08 | 0.08 |
| Net Block | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.04 | 0.02 | 0.02 | 1.68 | 1.68 |
| Current Assets, Loans and Advances | |||||
| Inventories | 0 | 0 | 0 | 0 | 0 |
| Sundry Debtors | 0 | 0 | 0 | 0 | 0 |
| Cash and Bank Balance | 0.47 | 7.66 | 6.87 | 0.44 | 0.38 |
| Loans and Advances | 9.91 | 2.57 | 3.82 | 3.41 | 3.51 |
| Less: Current Liab. and Prov. | |||||
| Current Liabilities | 0.12 | 0.12 | 0.03 | 0.05 | 0.05 |
| Provisions | -0.03 | 0.01 | 0.55 | 0.02 | 0.28 |
| Net Current Assets | 10.29 | 10.1 | 10.11 | 3.78 | 3.56 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 10.33 | 10.13 | 10.14 | 5.47 | 5.25 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0.61 |
If I had made LUMPSUM investment of ₹ 1,00,000
in CHEMO PHARMA LABORATORIES LTD.
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
